SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021131
Filing Date
2020-11-12
Accepted
2020-11-12 16:59:06
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 522694
2 ex31-1.htm EX-31.1 12452
3 ex31-2.htm EX-31.2 12367
4 ex32-1.htm EX-32.1 9213
  Complete submission text file 0001493152-20-021131.txt   3411187

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE eton-20200930.xml EX-101.INS 452555
6 XBRL SCHEMA FILE eton-20200930.xsd EX-101.SCH 47413
7 XBRL CALCULATION FILE eton-20200930_cal.xml EX-101.CAL 49800
8 XBRL DEFINITION FILE eton-20200930_def.xml EX-101.DEF 202962
9 XBRL LABEL FILE eton-20200930_lab.xml EX-101.LAB 344434
10 XBRL PRESENTATION FILE eton-20200930_pre.xml EX-101.PRE 259585
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7208 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38738 | Film No.: 201307721
SIC: 2834 Pharmaceutical Preparations